Sun Pharmaceutical Industries provides update on subsidiary
Sun Pharma Laboratories raises Rs 1000 crore
Sun Pharmaceutical Industries announced that Sun Pharma Laboratories , a wholly-owned subsidiary of the Company, has raised, on Private Placement Basis, Rs. 1000 crore by allotment of 10,000 (Ten Thousand) (ICRA) AAA / Stable Outlook Rated Unsecured Redeemable Non-Convertible Debentures of a face value of Rs. 10 lakh only each to be listed on BSE under two series with Series 1 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 24 months, and Series 2 debentures comprising of 5,000 debentures amounting to Rs 500 crore with a tenor of 39 months.Powered by Capital Market - Live News